KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilysys (AGYS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Agilysys (AGYS) over the last 16 years, with Q4 2025 value amounting to $81.5 million.

  • Agilysys' Cash & Equivalents rose 3405.47% to $81.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $81.5 million, marking a year-over-year increase of 3405.47%. This contributed to the annual value of $73.0 million for FY2025, which is 4958.9% down from last year.
  • According to the latest figures from Q4 2025, Agilysys' Cash & Equivalents is $81.5 million, which was up 3405.47% from $59.3 million recorded in Q3 2025.
  • In the past 5 years, Agilysys' Cash & Equivalents registered a high of $144.9 million during Q1 2024, and its lowest value of $54.9 million during Q3 2024.
  • For the 5-year period, Agilysys' Cash & Equivalents averaged around $96.8 million, with its median value being $101.5 million (2021).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 11259.08% in 2021, then crashed by 6144.36% in 2025.
  • Over the past 5 years, Agilysys' Cash & Equivalents (Quarter) stood at $115.1 million in 2021, then fell by 8.08% to $105.8 million in 2022, then rose by 9.81% to $116.2 million in 2023, then tumbled by 47.71% to $60.8 million in 2024, then skyrocketed by 34.05% to $81.5 million in 2025.
  • Its Cash & Equivalents was $81.5 million in Q4 2025, compared to $59.3 million in Q3 2025 and $55.6 million in Q2 2025.